Q3 2023 · 13F-HR
Artal Group S.A.holdings as filed
Filed 2023-11-13 · accession 0001053906-23-000011
$2.3M
Reported value
104
Positions
2023-09-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 148929102 | CAVA | CAVA GROUP INC | $980,405 | 42.0% | 32,007,990 | Common | SOLE |
| 528872302 | LXRX | LEXICON PHARMACEUTICALS INC | $128,133 | 5.49% | 117,553,284 | Common | SOLE |
| 60468T105 | MRTXEUR | MIRATI THERAPEUTICS INC | $88,175 | 3.78% | 2,024,226 | Common | SOLE |
| 07725L102 | ONC | BEIGENE LTD | $72,656 | 3.12% | 403,934 | Common | SOLE |
| 76155X100 | RVMD | REVOLUTION MEDICINES INC | $70,023 | 3.00% | 2,529,737 | Common | SOLE |
| 80706P103 | SRRK | SCHOLAR ROCK HLDG CORP | $64,322 | 2.76% | 9,059,507 | Common | SOLE |
| 03753U106 | APLSUSD | APELLIS PHARMACEUTICALS INC | $63,320 | 2.71% | 1,664,572 | Common | SOLE |
| 03152W109 | AM6 | AMICUS THERAPEUTICS INC | $49,401 | 2.12% | 4,062,567 | Common | SOLE |
| 61775R105 | MORFUSD | MORPHIC HLDG INC | $48,986 | 2.10% | 2,138,188 | Common | SOLE |
| 23282W605 | CYTK | CYTOKINETICS INC | $44,745 | 1.92% | 1,518,831 | Common | SOLE |
| 85205L107 | SWTXUSD | SPRINGWORKS THERAPEUTICS INC | $42,000 | 1.80% | 1,816,620 | Common | SOLE |
| 640979100 | NMRA | NEUMORA THERAPEUTICS INC | $39,546 | 1.70% | 2,802,702 | Common | SOLE |
| 15678U128 | CERE1EUR | CEREVEL THERAPEUTICS HLDNG I | $35,776 | 1.53% | 1,638,858 | Common | SOLE |
| 60468T105 | MRTXEUR | MIRATI THERAPEUTICS INC | $30,492 | 1.31% | 700,000 | CALL | SOLE |
| 00445A100 | — | ACELYRIN INC | $25,113 | 1.08% | 2,469,279 | Common | SOLE |
| 501575104 | KYMR | KYMERA THERAPEUTICS INC | $25,094 | 1.08% | 1,805,346 | Common | SOLE |
| 82686Q101 | SLN | SILENCE THERAPEUTICS PLC | $24,550 | 1.05% | 2,500,000 | Common | SOLE |
| 45253H101 | IMGNEUR | IMMUNOGEN INC | $23,997 | 1.03% | 1,512,113 | Common | SOLE |
| 449585108 | 1K0 | IGM BIOSCIENCES INC | $21,061 | 0.90% | 2,522,244 | Common | SOLE |
| 50127T109 | KURA | KURA ONCOLOGY INC | $18,405 | 0.79% | 2,018,056 | Common | SOLE |
| 00847G705 | AGENEUR | AGENUS INC | $17,663 | 0.76% | 15,631,235 | Common | SOLE |
| 81141R100 | SE | SEA LTD | $17,448 | 0.75% | 397,000 | Common | SOLE |
| 24823R105 | DNLI | DENALI THERAPEUTICS INC | $16,564 | 0.71% | 802,899 | Common | SOLE |
| 019818103 | — | ALLOVIR INC | $14,184 | 0.61% | 6,597,167 | Common | SOLE |
| 80810D103 | SDGR | SCHRODINGER INC | $14,135 | 0.61% | 500,000 | Common | SOLE |
| 92332V107 | VTYXUSD | VENTYX BIOSCIENCES INC | $14,074 | 0.60% | 405,239 | Common | SOLE |
| 02083G100 | NVLSEUR | ALPINE IMMUNE SCIENCES INC | $13,660 | 0.59% | 1,193,030 | Common | SOLE |
| 38000Q102 | GLYCEUR | GLYCOMIMETICS INC | $12,884 | 0.55% | 8,589,064 | Common | SOLE |
| 75525N107 | — | RAYZEBIO INC | $12,333 | 0.53% | 555,556 | Common | SOLE |
| 374163103 | GERN | GERON CORP | $11,800 | 0.51% | 5,565,889 | Common | SOLE |
| G76279101 | ROIV | ROIVANT SCIENCES LTD | $11,680 | 0.50% | 1,000,000 | Common | SOLE |
| 877619106 | TSHA | TAYSHA GENE THERAPIES INC | $11,575 | 0.50% | 3,663,104 | Common | SOLE |
| Y95308105 | WVE | WAVE LIFE SCIENCES LTD | $11,500 | 0.49% | 2,000,000 | Common | SOLE |
| 37148K100 | GBIOGBX | GENERATION BIO CO | $10,666 | 0.46% | 2,814,191 | Common | SOLE |
| 81578P106 | SEER | SEER INC | $10,498 | 0.45% | 4,750,000 | Common | SOLE |
| 92673K108 | VIGL | VIGIL NEUROSCIENCE INC | $10,285 | 0.44% | 1,908,135 | Common | SOLE |
| 816212104 | SELBUSD | SELECTA BIOSCIENCES INC | $9,685 | 0.42% | 9,136,635 | Common | SOLE |
| 690469101 | OVID | OVID THERAPEUTICS INC | $9,600 | 0.41% | 2,500,000 | Common | SOLE |
| 29479A108 | ERAS | ERASCA INC | $9,301 | 0.40% | 4,721,194 | Common | SOLE |
| 874039100 | TSM | TAIWAN SEMICONDUCTOR MFG LTD | $8,925 | 0.38% | 102,699 | Common | SOLE |
| 632307104 | NTRA | NATERA INC | $8,850 | 0.38% | 200,000 | Common | SOLE |
| 63009J107 | NBTX | NANOBIOTIX | $8,750 | 0.38% | 1,000,000 | Common | SOLE |
| 45826J105 | NTLA | INTELLIA THERAPEUTICS INC | $8,730 | 0.37% | 276,077 | Common | SOLE |
| 344174107 | FHTX | FOGHORN THERAPEUTICS INC | $8,604 | 0.37% | 1,720,720 | Common | SOLE |
| 76029N106 | REPL | REPLIMUNE GROUP INC | $8,555 | 0.37% | 500,000 | Common | SOLE |
| 760273102 | RPTX | REPARE THERAPEUTICS INC | $8,456 | 0.36% | 700,000 | Common | SOLE |
| 786700104 | SGMT | SAGIMET BIOSCIENCES INC | $8,138 | 0.35% | 924,771 | Common | SOLE |
| 45175G108 | — | IKENA ONCOLOGY INC | $8,008 | 0.34% | 1,849,513 | Common | SOLE |
| 05156V102 | AUPH | AURINIA PHARMACEUTICALS INC | $7,770 | 0.33% | 1,000,000 | Common | SOLE |
| 92790C104 | VRDN | VIRIDIAN THERAPEUTICS INC | $7,746 | 0.33% | 504,978 | Common | SOLE |
| 26818M108 | DYN | DYNE THERAPEUTICS INC | $7,303 | 0.31% | 815,085 | Common | SOLE |
| 23954D109 | DAWNGBX | DAY ONE BIOPHARMACEUTICALS I | $6,135 | 0.26% | 500,000 | Common | SOLE |
| 03152W109 | AM6 | AMICUS THERAPEUTICS INC | $6,080 | 0.26% | 500,000 | CALL | SOLE |
| 09203E105 | BDTX | BLACK DIAMOND THERAPEUTICS I | $5,874 | 0.25% | 2,046,517 | Common | SOLE |
| 87184Q206 | SYRS | SYROS PHARMACEUTICALS INC | $5,829 | 0.25% | 1,475,744 | Common | SOLE |
| 929033108 | — | VOR BIOPHARMA INC | $5,699 | 0.24% | 2,688,015 | Common | SOLE |
| 68217N105 | — | OMEGA THERAPEUTICS INC | $5,446 | 0.23% | 2,533,045 | Common | SOLE |
| 38341P102 | GOSS | GOSSAMER BIO INC | $5,330 | 0.23% | 6,399,819 | Common | SOLE |
| 36118A100 | — | FUSION PHARMACEUTICALS INC | $4,485 | 0.19% | 1,725,000 | Common | SOLE |
| 46565G104 | 5E7 | ITEOS THERAPEUTICS INC | $4,380 | 0.19% | 400,000 | Common | SOLE |
| 482497104 | BEKE | KE HLDGS INC | $4,268 | 0.18% | 275,000 | Common | SOLE |
| 92539P101 | — | VERVE THERAPEUTICS INC | $3,978 | 0.17% | 300,000 | Common | SOLE |
| 43906K100 | HOOKGBP | HOOKIPA PHARMA INC | $3,491 | 0.15% | 5,666,410 | Common | SOLE |
| 48553T106 | BZ | KANZHUN LIMITED | $3,337 | 0.14% | 220,000 | Common | SOLE |
| 87410C104 | — | TALARIS THERAPEUTICS INC | $2,569 | 0.11% | 914,262 | Common | SOLE |
| 83422E204 | SLDB | SOLID BIOSCIENCES INC | $2,291 | 0.10% | 909,219 | Common | SOLE |
| 00449L102 | 698 | ACHILLES THERAPEUTICS PLC | $2,052 | 0.09% | 2,255,375 | Common | SOLE |
| 50107A104 | KRON1USD | KRONOS BIO INC | $2,006 | 0.09% | 1,542,954 | Common | SOLE |
| 05370A108 | RNAGBP | AVIDITY BIOSCIENCES INC | $1,914 | 0.08% | 300,000 | Common | SOLE |
| 70450Y103 | PYPL | PAYPAL HLDGS INC | $1,871 | 0.08% | 32,000 | CALL | SOLE |
| 594918104 | MSFT | MICROSOFT CORP | $1,737 | 0.07% | 5,500 | Common | SOLE |
| 92826C839 | V | VISA INC | $1,725 | 0.07% | 7,500 | Common | SOLE |
| 005329107 | ADAG | ADAGENE INC | $1,530 | 0.07% | 1,000,000 | Common | SOLE |
| 023135106 | AMZN | AMAZON COM INC | $1,525 | 0.07% | 12,000 | Common | SOLE |
| 44975P103 | NBP | I MAB | $1,122 | 0.05% | 850,000 | Common | SOLE |
| 46333X108 | IRWD | IRONWOOD PHARMACEUTICALS INC | $1,064 | 0.05% | 110,532 | Common | SOLE |
| 23804L103 | DDOG | DATADOG INC | $1,048 | 0.04% | 11,500 | Common | SOLE |
| 98422T100 | — | XILIO THERAPEUTICS INC | $950 | 0.04% | 450,000 | Common | SOLE |
| 00653A107 | ADAPY | ADAPTIMMUNE THERAPEUTICS PLC | $884 | 0.04% | 1,133,775 | Common | SOLE |
| 02079K305 | GOOGL | ALPHABET INC | $720 | 0.03% | 5,500 | Common | SOLE |
| 231269309 | CRIS | CURIS INC | $692 | 0.03% | 105,000 | Common | SOLE |
| 852234103 | XYZ | BLOCK INC | $686 | 0.03% | 15,500 | Common | SOLE |
| 90138Q108 | — | 23ANDME HOLDING CO | $646 | 0.03% | 661,009 | Common | SOLE |
| 007903107 | AMD | ADVANCED MICRO DEVICES INC | $617 | 0.03% | 6,000 | Common | SOLE |
| 142038108 | CRBU | CARIBOU BIOSCIENCES INC | $504 | 0.02% | 105,347 | Common | SOLE |
| 64110L106 | NFLX | NETFLIX INC | $485 | 0.02% | 1,285 | Common | SOLE |
| 23255M204 | CYCN | CYCLERION THERAPEUTICS INC | $473 | 0.02% | 138,403 | Common | SOLE |
| 41358P205 | HARPUSD | HARPOON THERAPEUTICS INC | $403 | 0.02% | 100,000 | Common | SOLE |
| 45827U109 | INTA | INTAPP INC | $335 | 0.01% | 10,000 | Common | SOLE |
| 22788C105 | CRWD | CROWDSTRIKE HLDGS INC | $335 | 0.01% | 2,000 | Common | SOLE |
| 705573103 | PEGA | PEGASYSTEMS INC | $326 | 0.01% | 7,500 | Common | SOLE |
| N51517105 | 4PKB | LAVA THERAPEUTICS NV | $294 | 0.01% | 200,000 | Common | SOLE |
| 74275K108 | PCOR | PROCORE TECHNOLOGIES INC | $294 | 0.01% | 4,500 | Common | SOLE |
| 70450Y103 | PYPL | PAYPAL HLDGS INC | $292 | 0.01% | 5,000 | Common | SOLE |
| 07373V105 | BEAM | BEAM THERAPEUTICS INC | $264 | 0.01% | 10,975 | Common | SOLE |
| 433539202 | HIPO | HIPPO HLDGS INC | $191 | 0.01% | 24,000 | Common | SOLE |
| 02043Q107 | ALNY | ALNYLAM PHARMACEUTICALS INC | $166 | 0.01% | 936 | Common | SOLE |
| 04280A100 | ARWR | ARROWHEAD PHARMACEUTICALS IN | $146 | 0.01% | 5,440 | Common | SOLE |
| 78472W104 | SQZB | SQZ BIOTECHNOLOGIES CO | $129 | 0.01% | 1,606,309 | Common | SOLE |
| 49461C102 | J75 | KINETA INC | $106 | 0.00% | 31,055 | Common | SOLE |
| 729139105 | PLRX | PLIANT THERAPEUTICS INC | $26 | 0.00% | 1,490 | Common | SOLE |
| 81726A100 | — | SENTI BIOSCIENCES INC | $23 | 0.00% | 55,555 | Common | SOLE |
| 23255M105 | — | CYCLERION THERAPEUTICS INC | $2 | 0.00% | 552 | Common | SOLE |
| 603693102 | — | MINK THERAPEUTICS INC | $2 | 0.00% | 1,916 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.